Related references
Note: Only part of the references are listed.Luminescent lanthanide complexes for reactive oxygen species biosensing and possible application in Alzheimer's diseases
Chantal Galaup et al.
FEBS JOURNAL (2022)
Synthesis of novel sulfonamides with anti-Alzheimer and antioxidant capacities
Nihal Gok et al.
ARCHIV DER PHARMAZIE (2021)
Direct Activation of Protein Phosphatase 2A (PP2A) by Tricyclic Sulfonamides Ameliorates Alzheimer's Disease Pathogenesis in Cell and Animal Models
Hui Wei et al.
NEUROTHERAPEUTICS (2020)
Structure-activity relationships of sulfonamides derived from carvacrol and their potential for the treatment of Alzheimer's disease
Marcia Maria de Souza et al.
RSC MEDICINAL CHEMISTRY (2020)
Multifunctional hybrid sulfonamides as novel therapeutic agents for Alzheimer's disease
Rayala Swetha et al.
FUTURE MEDICINAL CHEMISTRY (2019)
BACE1 Cleavage Site Selection Critical for Amyloidogenesis and Alzheimer's Pathogenesis
Shuting Zhang et al.
JOURNAL OF NEUROSCIENCE (2017)
Novel Sulfamethoxazole Ureas and Oxalamide as Potential Antimycobacterial Agents
Martin Kratky et al.
MOLECULES (2017)
Current pharmacotherapy and putative disease-modifying therapy for Alzheimer's disease
Akanksha Kulshreshtha et al.
NEUROLOGICAL SCIENCES (2016)
Alzheimer's Disease and Hippocampal Adult Neurogenesis; Exploring Shared Mechanisms
Carolyn Hollands et al.
FRONTIERS IN NEUROSCIENCE (2016)
Sulfonamides as multifunctional agents for Alzheimer's disease
Seema Bag et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Neuronal response in Alzheimer's and Parkinson's disease: the effect of toxic proteins on intracellular pathways
Shohreh Majd et al.
BMC NEUROSCIENCE (2015)
Synthesis of a new series of N4-substituted 4-(2-aminoethyl) benzenesulfonamides and their inhibitory effect on human carbonic anhydrase cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII
Jaroslaw Slawinski et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Carbonic anhydrase inhibitors. Synthesis of a novel series of 5-substituted 2,4-dichlorobenzenesulfonamides and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII
Jaroslaw Slawinski et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Genetic markers for diagnosis and pathogenesis of Alzheimer's disease
Dong Hee Kim et al.
GENE (2014)
Oxidative Stress in Alzheimer's Disease: Why Did Antioxidant Therapy Fail?
Torbjorn Persson et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2014)
The global prevalence of dementia: A systematic review and metaanalysis
Martin Prince et al.
ALZHEIMERS & DEMENTIA (2013)
Diaryl Hydrazones as Multifunctional Inhibitors of Amyloid Self-Assembly
Bela Toeroek et al.
BIOCHEMISTRY (2013)
Anticancer carbonic anhydrase inhibitors: a patent review (2008-2013)
Simona Maria Monti et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2013)
Antiobesity carbonic anhydrase inhibitors: a literature and patent review
Andrea Scozzafava et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2013)
Synthesis, characterization and antimicrobial activity of novel xanthene sulfonamide and carboxamide derivatives
Muharrem Kaya et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2013)
Protective Effects of Troxerutin on β-Amyloid (1-42)-Induced Impairments of Spatial Learning and Memory in Rats
S. Babri et al.
NEUROPHYSIOLOGY (2012)
Searching for new animal models of Alzheimer's disease
Roberta Epis et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Effect of Donepezil on Cognition in Severe Alzheimer's Disease: A Pooled Data Analysis
Jeffrey Cummings et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
MECHANISMS OF DISEASE Alzheimer's Disease
Henry W. Querfurth et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Begacestat (GSI-953): A Novel, Selective Thiophene Sulfonamide Inhibitor of Amyloid Precursor Protein γ-Secretase for the Treatment of Alzheimer's Disease
Robert L. Martone et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Lipid peroxidation and antioxidant enzyme activities in vascular and Alzheimer dementias
Angela Casado et al.
NEUROCHEMICAL RESEARCH (2008)
Alzheimer's Disease and mild cognitive impairment
Brendan J. Kelley et al.
NEUROLOGIC CLINICS (2007)
Recent developments in natural and synthetic drug research for Alzheimer's disease
Gurdal Orhan et al.
LETTERS IN DRUG DESIGN & DISCOVERY (2006)
Oxidative stress in Alzheimer patients in different stages of the disease
P Zafrilla et al.
CURRENT MEDICINAL CHEMISTRY (2006)
Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer β-amyloid peptide in rodent
NH Greig et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Enhanced ROS-generation in lymphocytes from Alzheimer's patients
S Leutner et al.
PHARMACOPSYCHIATRY (2005)
Neuroprotection by crocetin in a hemi-parkinsonian rat model
AS Ahmad et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2005)
Acetylcholinesterase: 'classical' and 'non-classical' functions and pharmacology
I Silman et al.
CURRENT OPINION IN PHARMACOLOGY (2005)
Twenty years of the Alzheimer's disease amyloid hypothesis: A genetic perspective
RE Tanzi et al.
CELL (2005)
Peroxide detoxification by brain cells
R Dringen et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2005)
Aβ Aggregation inhibitors.: Part 1:: Synthesis and biological activity of phenylazo benzenesulfonamides
SJ Lin et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2004)
Neurodegenerative diseases and oxidative stress
KJ Barnham et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Deciphering the molecular basis of memory failure in Alzheimer's disease
DM Walsh et al.
NEURON (2004)
The inhibition of γ-secretase as a therapeutic approach to Alzheimer's disease
T Tomita et al.
DRUG NEWS & PERSPECTIVES (2004)
Carbonic anhydrase inhibitors. Inhibition of tumor-associated isozyme IX by halogenosulfanilamide and halogenophenylaminobenzolamide derivatives
MA Ilies et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Neurobiology of butyrylcholinesterase
S Darvesh et al.
NATURE REVIEWS NEUROSCIENCE (2003)
Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease
P Rinaldi et al.
NEUROBIOLOGY OF AGING (2003)
Structural and dynamic features of Alzheimer's Aβ peptide in amyloid fibrils studied by site-directed spin labeling
M Török et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Alzheimer's disease and the basal forebrain cholinergic system:: relations to β-amyloid peptides, cognition, and treatment strategies
DS Auld et al.
PROGRESS IN NEUROBIOLOGY (2002)
Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics
J Hardy et al.
SCIENCE (2002)
Share Paper
